Minorities more likely to view generic drugs as inferior, study finds
October 24, 2012 by Milly Dawson in Medications
Negative perceptions about generic drugs are more widespread among ethnic minorities than among whites, finds a new study in Ethnicity & Disease. Greater use of generic drugs, say the authors, could significantly reduce two major problems: patients' failing to take medications properly because they cannot afford brand name drugs and the amount spent overall on prescription medications.
"A lot of people can't afford their medicine. They end up in the ER for something preventable," said Anthony Omojasola, DrPH, the study's lead author. "We wanted to see if people were aware of generic drug discount programs and, if they were aware, why they would or would not participate."
Discount programs offered by retailers such as Wal-Mart offer many common generic drugs for $4 for a 30-day supply. The authors add that most doctors seldom ask patients about problems paying for prescriptions and patients seldom raise such problems with physicians.
The study results come from a survey of Houston residents with incomes under $30,000 with a chronic condition requiring a prescription drug or a family member with such a condition. Most respondents were female (77 percent) and African-American (67 percent).
The researchers found no significant differences by race/ethnicity in the use of generic drug discount programs. About 75 percent of survey participants agreed that generics are "equal in quality" to, just "as safe as" and "just as effective as" brand name drugs. However, negative perceptions about the potential for side effects and about "inferiority" of generics compared to brand name drugs were more pronounced among minority group members than among white participants.
Compared to non-Hispanic whites, blacks and Hispanics were 10 times as likely to agree that generic drugs had more side effects than brand name ones. They were also 4 times as likely as whites to agree that generics were inferior to brand name drugs. Still, negative perceptions did not prevent minorities from using generic drugs.
Gerard Anderson, Ph.D. of Johns Hopkins School of Public Health commented that while generic drugs are therapeutically equivalent to brand name drugs, patients often lack this information; generic drug companies don't advertise like companies promoting brand name drugs.
Anderson added the fact that minorities are more suspicious of generic drugs is not so surprising, he said, "What is more surprising is that in spite of this suspicion they are willing to participate in generic substitution programs."
Omojasola's team called for physicians and pharmacists to better educate patients about the general equivalency of generic and brand name drugs to reduce concerns about generic substitutions and medication costs for patients and society.
More information: A. Omojasola, DrPH; M. Hernandez, MS; S. Sansgiry, PhD; L. Jones, Ph.D., Perception of Generic Prescription Drugs And Utilization Of Generic Drug Discount Programs, Ethnicity & Disease, Volume 22, Autumn 2012.
Journal reference:
Ethnicity & Disease
Provided by
Health Behavior News Service
-
Use of $4 generic drug programs could save society billions of dollars, study shows
Mar 14, 2011 |
not rated yet |
0
-
Americans turn to generic medications in 2010: report
Apr 22, 2011 |
not rated yet |
0
-
Variation in make-up of generic epilepsy drugs can lead to dosing problems
Jun 30, 2011 |
not rated yet |
0
-
No difference in brand name and generic drugs regarding thyroid dysfunction
Jul 11, 2011 |
not rated yet |
0
-
Substitution of brand name with generic drug proves safe for transplant recipients
Sep 13, 2011 |
not rated yet |
0
-
Motion perception revisited: High Phi effect challenges established motion perception assumptions
Apr 23, 2013 |
3 / 5 (2) |
2
-
Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update)
Apr 02, 2013 |
4.5 / 5 (11) |
5
-
The visual system as economist: Neural resource allocation in visual adaptation
Mar 30, 2013 |
5 / 5 (2) |
9
-
Separate lives: Neuronal and organismal lifespans decoupled
Mar 27, 2013 |
4.9 / 5 (8) |
0
-
Sizing things up: The evolutionary neurobiology of scale invariance
Feb 28, 2013 |
4.8 / 5 (10) |
14
-
Pressure-volume curve: Elastic Recoil Pressure don't make sense
May 18, 2013
-
If you became brain-dead, would you want them to pull the plug?
May 17, 2013
-
MRI bill question
May 15, 2013
-
Ratio of Hydrogen of Oxygen in Dessicated Animal Protein
May 13, 2013
-
Alcohol and acetaminophen
May 13, 2013
-
Marie Curie's leukemia
May 13, 2013
- More from Physics Forums - Medical Sciences
More news stories
Breakup of physician, drug company relationship could improve health care, cut cost
A new report suggests that improved health care and significant reductions in drug costs might be attained by breaking up the age-old relationship between physicians and drug company representatives who promote the newest, ...
Medications
17 hours ago |
5 / 5 (1) |
0
FDA has safety concerns on Merck insomnia drug
Federal health regulators say an experimental insomnia drug from Merck can help patients fall asleep, but it also carries worrisome side effects, including daytime drowsiness and suicidal thinking.
Medications
19 hours ago |
not rated yet |
0
US adviser on board of firm that sold anthrax drug
(AP)—Former Navy Secretary Richard J. Danzig, who has served as a bio-warfare adviser to the president, the Pentagon, and the Department of Homeland Security, urged the government to stockpile an anti-anthrax drug while ...
Medications
May 20, 2013 |
5 / 5 (1) |
0
Acne pill benefits outweigh blood clot risk: EU agency
Europe's medicines watchdog said Friday the benefits of acne drug Diane-35, also widely used as a contraceptive, outweigh the risk of developing blood clots in the veins—when correctly prescribed.
Medications
May 17, 2013 |
not rated yet |
0
First influenza vaccine brought to clinical testing
Singapore's Agency for Science, Technology and Research (A*STAR) and Switzerland's Cytos Biotechnology AG today announced that the first healthy volunteer has been dosed in a Phase 1 clinical trial with their ...
Medications
May 17, 2013 |
5 / 5 (1) |
1
Holding drivers' attention
Each day, an average of nine people are killed in the United States and more than 1,000 injured by drivers doing something other than driving.
New theory offers clues to vital 'repair and maintenance' role of sleep
(Medical Xpress)—We spend about a third of our life asleep, but why we need to do so remains a mystery. In a recent publication, researchers at University of Surrey and University College London suggest a new hypothesis, ...
Genetic predictors of postpartum depression uncovered
Johns Hopkins researchers say they have discovered specific chemical alterations in two genes that, when present during pregnancy, reliably predict whether a woman will develop postpartum depression.
Nobel laureate plays down flu pandemic scaremongering
A Nobel prize-winning scientist Tuesday played down "shock-horror scenarios" that a new virus strain will emerge with the potential to kill millions of people.
Study puts Huntington's disease trials on TRACK
(Medical Xpress)—A three-year multinational study has tracked and detailed the progression of Huntington's disease (HD), predicting clinical decline in people carrying the HD gene more than 10 years before ...
Child maltreatment increases risk of adult obesity
Children who have suffered maltreatment are 36% more likely to be obese in adulthood compared to non-maltreated children, according to a new study by King's College London. The authors estimate that the prevention or effective ...